Arteriovenous Graft Thrombosis

1

Review clinical trials related to Arteriovenous Graft Thrombosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Changes in Regional Ventilation-Perfusion Match Following Percutaneous Transluminal Angioplasty for Arteriovenous Graft Thrombosis

Patients with end-stage renal disease (ESRD) often require arteriovenous grafts (AVG) for hemodialysis. AVG thrombosis is a common complication, usually managed by percutaneous transluminal angioplasty (PTA) to restore blood flow. PTA achieves patency by balloon-mediated compression and fragmentation of thrombus. Small thrombus fragments may enter the venous circulation and cause transient pulmonary microembolism, leading to ventilation-perfusion (V/Q) mismatch. This study uses electrical impedance tomography (EIT) to noninvasively monitor short-term changes in regional ventilation and perfusion during and after PTA, exploring the immediate pulmonary physiological consequences of thrombus fragmentation and revascularization in dialysis patients.

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: First Affiliated Hospital of Wannan Medical CollegeUpdated: May 29, 2026Locations: 1
Eligibility criteria

Age ≥ 18 years. [+4]

Severe respiratory failure incompatible with supine position. [+5]